Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway.

Zhang X, Liu K, Zhang T, Wang Z, Qin X, Jing X, Wu H, Ji X, He Y, Zhao R.

Oncotarget. 2017 Jan 3;8(1):1541-1554. doi: 10.18632/oncotarget.13652.

2.

PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2.

Dong H, Ma L, Gan J, Lin W, Chen C, Yao Z, Du L, Zheng L, Ke C, Huang X, Song H, Kumar R, Yeung SC, Zhang H.

Oncogene. 2017 Jan 19;36(3):410-422. doi: 10.1038/onc.2016.213. Epub 2016 Jun 27.

3.

Constitutive Endocytosis of VEGFR2 Protects the Receptor against Shedding.

Basagiannis D, Christoforidis S.

J Biol Chem. 2016 Aug 5;291(32):16892-903. doi: 10.1074/jbc.M116.730309. Epub 2016 Jun 13.

PMID:
27298320
4.

Personalized medicine in cystic fibrosis: genistein supplementation as a treatment option for patients with a rare S1045Y-CFTR mutation.

Arora K, Yarlagadda S, Zhang W, Moon C, Bouquet E, Srinivasan S, Li C, Stokes DC, Naren AP.

Am J Physiol Lung Cell Mol Physiol. 2016 Aug 1;311(2):L364-74. doi: 10.1152/ajplung.00134.2016. Epub 2016 Jun 3.

PMID:
27261451
5.

Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibition.

Raja SM, Desale SS, Mohapatra B, Luan H, Soni K, Zhang J, Storck MA, Feng D, Bielecki TA, Band V, Cohen SM, Bronich TK, Band H.

Oncotarget. 2016 Mar 1;7(9):10522-35. doi: 10.18632/oncotarget.7231.

6.

Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment.

Drescher C, Konishi M, Ebner N, Springer J.

J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):303-11. doi: 10.1002/jcsm.12082. Epub 2015 Nov 18. Review.

7.

Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers.

Ségaliny AI, Tellez-Gabriel M, Heymann MF, Heymann D.

J Bone Oncol. 2015 Jan 23;4(1):1-12. doi: 10.1016/j.jbo.2015.01.001. eCollection 2015 Mar. Review.

8.

Regulation of CTP Synthase Filament Formation During DNA Endoreplication in Drosophila.

Wang PY, Lin WC, Tsai YC, Cheng ML, Lin YH, Tseng SH, Chakraborty A, Pai LM.

Genetics. 2015 Dec;201(4):1511-23. doi: 10.1534/genetics.115.180737. Epub 2015 Oct 19.

9.

The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression.

He C, Mao D, Hua G, Lv X, Chen X, Angeletti PC, Dong J, Remmenga SW, Rodabaugh KJ, Zhou J, Lambert PF, Yang P, Davis JS, Wang C.

EMBO Mol Med. 2015 Nov;7(11):1426-49. doi: 10.15252/emmm.201404976.

10.

From bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer?

Wu VS, Kanaya N, Lo C, Mortimer J, Chen S.

J Steroid Biochem Mol Biol. 2015 Sep;153:45-53. doi: 10.1016/j.jsbmb.2015.05.005. Epub 2015 May 18. Review.

11.

Maintenance of glia in the optic lamina is mediated by EGFR signaling by photoreceptors in adult Drosophila.

Lee YM, Sun YH.

PLoS Genet. 2015 Apr 24;11(4):e1005187. doi: 10.1371/journal.pgen.1005187. eCollection 2015 Apr.

12.

Extracellular molecules involved in cancer cell invasion.

Stivarou T, Patsavoudi E.

Cancers (Basel). 2015 Jan 26;7(1):238-65. doi: 10.3390/cancers7010238. Review.

13.

Gene expression microarray analysis of the spinal trigeminal nucleus in a rat model of migraine with aura.

Liu R, Yu S, Li F, Qiu E.

Neural Regen Res. 2012 Sep 5;7(25):1931-8. doi: 10.3969/j.issn.1673-5374.2012.25.002.

14.

ADAM10 controls collagen signaling and cell migration on collagen by shedding the ectodomain of discoidin domain receptor 1 (DDR1).

Shitomi Y, Thøgersen IB, Ito N, Leitinger B, Enghild JJ, Itoh Y.

Mol Biol Cell. 2015 Feb 15;26(4):659-73. doi: 10.1091/mbc.E14-10-1463. Epub 2014 Dec 24.

15.

Protein neddylation: beyond cullin-RING ligases.

Enchev RI, Schulman BA, Peter M.

Nat Rev Mol Cell Biol. 2015 Jan;16(1):30-44. doi: 10.1038/nrm3919. Review.

16.

Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.

Chung BM, Tom E, Zutshi N, Bielecki TA, Band V, Band H.

World J Clin Oncol. 2014 Dec 10;5(5):806-23. doi: 10.5306/wjco.v5.i5.806. Review.

17.

Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis.

Cipriani P, Di Benedetto P, Capece D, Zazzeroni F, Liakouli V, Ruscitti P, Pantano I, Berardicurti O, Carubbi F, Alesse E, Giacomelli R.

Fibrogenesis Tissue Repair. 2014 Sep 15;7:13. doi: 10.1186/1755-1536-7-13. eCollection 2014.

18.

Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover.

Hong X, Nguyen HT, Chen Q, Zhang R, Hagman Z, Voorhoeve PM, Cohen SM.

EMBO J. 2014 Nov 3;33(21):2447-57. doi: 10.15252/embj.201489385. Epub 2014 Sep 1.

19.

Protein degradation machinery is present broadly during early development in the sea urchin.

Zazueta-Novoa V, Wessel GM.

Gene Expr Patterns. 2014 Jul;15(2):135-41. doi: 10.1016/j.gep.2014.06.002. Epub 2014 Jun 22.

20.

USP8 modulates ubiquitination of LRIG1 for Met degradation.

Oh YM, Lee SB, Choi J, Suh HY, Shim S, Song YJ, Kim B, Lee JM, Oh SJ, Jeong Y, Cheong KH, Song PH, Kim KA.

Sci Rep. 2014 May 15;4:4980. doi: 10.1038/srep04980.

Supplemental Content

Support Center